UK HealthCare logo

Michael F. Daily, MD, FACS

Surgical Director, Adult and Pediatric Renal Transplantation Program and Pancreas Transplantation Program

Practice areas

  • Pediatric Kidney Transplant Team
  • Transplant Surgery
  • Transplant: Kidney
  • Transplant: Pancreas

Faculty rank

Associate Professor of Surgery

Clinic information

Clinical interests

  • Kidney and Pancreas Transplantation
  • Laparoscopic Donor Nephrectomies
  • Liver Resections and Reconstructions



University of Utah, School of Medicine, Salt Lake City


University of Utah, School of Medicine, Salt Lake City


University of Pittsburgh Medical Center

Certifications or Special training

American Board of Surgery
Fellow of the American College of Surgeons

Additional information


My name Michael F. Daily; I am the Surgical Director of the Adult and Pediatric Kidney Transplant Program and the Pancreas Transplant Program. I am originally from the west, but have been at the University of Kentucky for over 4 years. I graduated from college in Montana at Carroll College. I then went to Graduate School at California State University, Northridge.

I was working for a pharmaceutical company in New Mexico when I applied to Medical School. In medical school at the University of Utah, is when I discovered an interest in Surgery, which led to Transplantation Surgery. My Transplant Surgery Fellowship was at the Thomas E. Starzl Transplantation Institute in Pittsburgh. From there I took a job at the University of California, Davis. I moved to Kentucky when the opportunity became available to engage in Transplant Surgery without living in a big city.

My interests include adult and pediatric kidney transplant, pancreas transplant, live donor kidney transplant, dialysis access including peritoneal dialysis catheters, liver masses, and resections.


Kanthawar P, Mei X, Daily MF, Chandarana J, Shah M, Berger J, Castellanos AL, Marti F, Gedaly R. Kidney Transplant Outcomes in the Super Obese: A National Study From the UNOS Dataset. World J Surg. 2016 Jun 22.

Vilchez V, Turcios L, Zaytseva Y, Stewart R, Lee EY, Maynard E, Shah MB, Daily MF, Tzeng CD, Davenport D, Castellanos AL, Krohmer S, Hosein PJ, Evers BM, Gedaly R. Cancer stem cell marker expression alone and in combination with microvascular invasion predicts poor prognosis in patients undergoing transplantation for hepatocellular carcinoma. Am J Surg. 2016 Feb 27.

Vilchez V, Shah MB, Daily MF, Pena L, Tzeng CW, Davenport D, Hosein PJ, Gedaly R, Maynard E. Long-term outcome of patients undergoing liver transplantation for mixed hepatocellular carcinoma and cholangiocarcinoma: an analysis of the UNOS database. HPB (Oxford). 2016 Jan;18(1):29-34.

Dela Cruz AC, Vilchez V, Kim S, Barnes B, Ravinuthala A, Zanni A, Galuppo R, Sourianarayanane A, Patel T, Maynard E, Shah MB, Daily MF, Uhl T, Esser K, Gedaly R. A prospective analysis of factors associated with decreased physical activity in patients with cirrhosis undergoing transplant evaluation. Clin Transplant. 2015 Nov;29(11):958-64.

Sundar Alagusundaramoorthy S, Vilchez V, Zanni A, Sourianarayanane A, Maynard E, Shah M, Daily MF, Pena LR, Gedaly R. Role of transplantation in the treatment of benign solid tumors of the liver: a review of the United Network of Organ Sharing data set. JAMA Surg. 2015 Apr;150(4):337-42.